Qualitative Interviews to Provide In-Depth Understanding of the Impact of Non-Small Cell Lung Cancer (Nsclc) and Its Treatment on of the Lives of Patients and Their Families/Caregivers

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.1238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.17-11 Pattern and Survival Impact of Neoadjuvant Treatment of Non-Small Cell Lung Cancer (NSCLC) in a Prospective Lung Resection Cohort

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Impact of Age and Comorbidity on Non–Small-Cell Lung Cancer Treatment in Older Veterans

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Gemcitabine in Non-Small Cell Lung Cancer (NSCLC): The Evidence of Its Therapeutic Value in Molecular Age

Clinical Medicine Reviews in Oncology
2010English

Pcn120 - Epidemiology and Costs of Non-Small Cell Lung Cancer (Nsclc) in Austria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

P3.15-30 Treatment Patterns and Survival of Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Era of Novel Therapies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-129 Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Innovations in the Treatment of Non-Small Cell Lung Cancer

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy